[1]
DeMoss VRD, Gottlieb D, Shaw PD, Eds. Mechanisms of action and biosynthesis of antibiotics. New York: Springer-Verlag 1967; 2: pp. 77-81.
[20]
Numan M, Bashir S, Mumtaz R, et al. Therapeutic applications of bacterial pigments: a review of current status and future opportunities. 3 Biotech 2018; 8(4): 207.
[21]
May G, Lenk W, Ott H. Trans-hydroxyviolacein, process for preparing it pure and its use for the prophylaxis and therapy of viral diseases. DE3813465, 1989.
[22]
Durán N, Haun M. Production process and purification process and antitumoral activity of 3-[1,2-dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one. BR970 2918-1, 1997.
[23]
Durán N, Rettori D. Stationary tray bioreactor for the bacterial metabolite production. BR9702986-6, 1997.
[24]
Mendes AS, De Carvalho EJE, Duarte MCT, Durán N, Bruns RE. Violacein and deoxyviolacein production process optimized by factorial design and analysis of response surface by Chromobacterium violaceum. BR0100199-0, 2001.
[25]
Bhaskaran K. Process for the production of violacein and its derivative deoxyviolacen containing bioactive pigment from Chromobacterium sp. MTCC5522, 2011.
[26]
Zheng KIH, Chen H, Wang JD, et al. Chromobacterioum violaceum strain and application thereof. CN103173390B, 2014.
[27]
Lyu J, Zhang S, Liu L, et al. High-violacein-yield Janthinobacterium lividum and application thereof. CN104293703 (A), 2015.
[28]
Yoon SH, Lee CM, Kwon SW, Koo BS, Baek HJ. Novel microorganism producing violacein. KR20150104663A, 2016.
[29]
May G, Ott H. Treatment of prophylaxis of polio and herpes virus infections - comprise administration of 3-(di:hydro-5-(hydroxy-1H- indolyl-2-oxo-3H-pyrrolidene)-di:hydro-2H-indole. DE 3935066, 1991.
[30]
Durán N, De Azevedo MBM, Alderete J. Process of formulation of violacein/cyclodextrin for using as antibiotic, antitumoral, antiviral and as trypanocide. BR9801307-6, 1998.
[31]
Alves OL, Gimenez I, De Azevedo MMM, Durán N, Melo PS. Pharmacological use of cyclodextrin-Au-Thiol-derived nanoparticles/hydrophobic compound as antitumor, antibacterial, antiviral and/or antiparasitic, their process of obtaining and their formulation. BR0502657-1, 2005.
[32]
De Vasconcelos ATR, Simpson AJG, Abreu HNS, et al. Gene-coding polynucleotides of the chromosome of the bacterium Chromobacterium violaceum, expression and activity of these polynucleotides and their applications. WO2004056960A3, 2004.
[33]
Sarmiento JJP, Cardozo VF, Durán N, et al. Composition containing biological silver nanoparticles and a pigment produced by Chromobacterium violaceum with antibacterial activity. BR1020160033730, 2016.
[34]
Lee CS, Lee JH, Kwon JH, Mitchell RJ, Choi SY. Antibiotic medical fabric with violacein supported particle and making process thereof. KR20160050468(A), 2016.
[35]
Mitchell RJ. Antimicrobial composition comprising Bdellovibrio bacteriovorus and violacein. KR20190110886 (A), 2019.
[36]
Kim W. Nanoparticle composition having antibacterial and pyrogenic properties and its manufacturing method. US10744560, 2020.
[37]
Durán N, De Souza AO. Process of violacein application as antimycobacterial compound. BR0101346-7, 2001.
[38]
Xing X, Sun Y, Zhang C. Violacein and/or deoxyviolacein for treating colon cancer. CN108853094 (A), 2018.
[41]
Enomoto K, Hosokawa K. Protein kinase inhibitor, method for producing the same, medicinal composition for treating cancer and reagent. JP2010126469 (A), 2010.
[42]
Xing X, Sun Y, Zhang C. Violacein and/or deoxyviolacein for promoting wound healing and hemoglutination. CN107865866 (A), 2018.
[43]
Paik SH, Kang HS, Jang IH, et al. The antiparasitic and antifungal agent containing violacein and the method of it. KR20060018386 KR100802494B, 2006.
[44]
Jaegon K, Kang HS, Soyoung K, et al. Insecticide and fungicide containing violacein, and their preparation method. KR20070088150 A, 2007.
[45]
Costa FTM, Justo GZ, Durán N, Nogueira PA, Lopes SCP. Uso da violaceina na forma livre ou encapsulada em sistemas polimericos como antimalárico (In Portugues). BR056399-0, 2005.
[46]
Costa FTM, Justo GZ, Durán N, Nogueira PA, Lopes SCP. Use of violacein, in free or encapsulated form in polymeric systems as antimalarial. BR0506399-0, 2020.
[47]
Asolkar R, Huang H, Koivunen M, Marrone P. Chromobacterium bioactive compositions and metabolites. US9187531 (B2), 2015.
[48]
Asolkar R, Nanmath J, Marrone P. Chromobacterium formulations, compositions, metabolites, and their uses. BR-112014009140-A2, US9259007-B2, 2016.
[49]
Aoki S, Nomura T. Production of natural antimicrobial antioxidant and its cosmetic formulation. JPH10139612 (A), 1998.
[50]
Durán N, De Azevedo MMM. Polymeric nanoparticle incorporating a compound with pharmaceutical or cosmetic properties, its process of obtaining and cosmetic or pharmaceutical composition containing the polymeric nanoparticles. BR0404306-5, 2004.
[51]
Meiring U, Lanzendoerfer G, Riedel H, et al. Cosmetic preparation, useful e.g. for the protection of skin and (semi)mucous membrane against bacteria and/or virus, comprises violacein dye in combination with lipophilic and/or hydrophilic substances. DE102005051869 (A1), 2007.
[52]
Hidachi K, Ueno M, Kishi H, et al. Cosmetics, pharmaceuticals, and quasi drugs containing violacein. JP2015105264 (A), 2015.
[53]
Wang YW, Xiao RZ. Use of natural pigment as nail polish pigment enabling to develop a healthy and environmentally friendly nail polish pigment. TW201720877A, TW1570191B, 2017.
[54]
Minbiole KPC, Harris R. Probiotic composition and process thereof. US8506952 B2, 2013.
[55]
Nomura T. Production of natural dye and dyeing with the dye. JPH06253864 (A), 1994.
[56]
Shirata A, Tsukamoto Y, Kato H, Hata T, Yasui H, Kojima A. Bluish purple pigment produced by bacterium and its use as dye or coloring additive JPH10113169 (A), 1998.
[57]
Hata T, Kato H, Kojima A, et al. Bluish purple pigment produced by bacterium and its use as dye or coloring additive. JPH10113169A, 1998.
[58]
Kato H, Hata T, Shirata A, Tsukamoto Y. Treatment for improving light resistance of bluish violet pigment. JPH 11152687 A, 1999.
[59]
Wan Z, Rozi AM, Bin MI, et al. A method for dyeing polyester fabrics using colorant extracted from Chromobacterium violaceum. MY150969-A, 2014.
[60]
Lee JH, Kwon JH, Lee CS, Mitchell RJ, Seong Y. A manufacturing method of violacein coated fiber and violacein coated fiber manufactured thereby. KR20180056295 (A), 2018.
